Alzheimer's Disease Innovations

Alzheimer’s disease is an irreversible, progressive brain disorder that slowly destroys memory and thinking skills, and eventually the ability to carry out the simplest tasks. In most people with Alzheimer’s, symptoms first appear in their mid-60s. Estimates vary, but experts suggest that more than 5 million Americans may have Alzheimer’s.

Researchers and inventors at Vanderbilt are working to develop technologies that could one day treat or prevent this debilitating disease. Below is a list of our current technologies related to Alzheimer's Disease.

Small Molecule Theraputics That Target the Muscarinic Acetylcholine Receptor 1 For The Treatment of Alzheimer's Disease    
Small Molecule mGlu3 NAMs as Therapeutics for CNS Disorders
Metabolic Labeling Reagents for Chondroitin Sulfate
Genome-wide Analysis of Gene-Gene Interaction in Alzheimer Disease